Patrick Dorr
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 7
- SARS-CoV-2 and COVID-19 Research 2
- Virology 9
- HIV Research and Treatment 9
- Co-authors
- Manos Perros (7 shared papers)Mike Westby (4 shared papers)Julie Mori (2 shared papers)Caroline Smith‐Burchnell (2 shared papers)Paul Griffin (2 shared papers)Anthony Wood (2 shared papers)Malcolm Macartney (2 shared papers)Carolyn Napier (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (1 paper)Journal of Hepatology (1 paper)Archives of Virology (1 paper)Antiviral Research (1 paper)Cytometry Part B Clinical Cytometry (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Patrick Dorr
17 papers receiving 1.4k citations
Patrick Dorr's Hit Papers
Peers
Comparison fields: 5 of 87
- Virology 855
- Infectious Diseases 571
- Immunology 283
- Hepatology 71
- Molecular Biology 379
Countries citing papers authored by Patrick Dorr
This map shows the geographic impact of Patrick Dorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Dorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Dorr more than expected).
Fields of papers citing papers by Patrick Dorr
This network shows the impact of papers produced by Patrick Dorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Dorr. The network helps show where Patrick Dorr may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Dorr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity Hit paper breakdown → | 2005 | 910 |
| 2 | 2006 | 273 | |
| 3 | 2003 | 69 | |
| 4 | 1989 | 44 | |
| 5 | 2010 | 32 | |
| 6 | 2005 | 23 | |
| 7 | 2022 | 20 | |
| 8 | 2008 | 14 | |
| 9 | 2009 | 13 | |
| 10 | 2024 | 11 | |
| 11 | 2019 | 9 | |
| 12 | 2011 | 8 | |
| 13 | 2007 | 3 | |
| 14 | 2020 | 2 | |
| 15 | 1993 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2017 | 1 |
About Patrick Dorr
Patrick Dorr is a scholar working on Infectious Diseases, Virology, Immunology, Epidemiology and Molecular Biology, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (7 papers), Immune Cell Function and Interaction (7 papers), Hepatitis C virus research (3 papers), Hepatitis B Virus Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cytomegalovirus and herpesvirus research (1 paper) and Microbial Fuel Cells and Bioremediation (1 paper). The work is most often cited by research in Virology (855 citations), Infectious Diseases (571 citations), Immunology (283 citations), Hepatology (71 citations) and Molecular Biology (379 citations). Patrick Dorr has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Manos Perros, Mike Westby, Julie Mori, Caroline Smith‐Burchnell, Paul Griffin, Anthony Wood, Malcolm Macartney, Carolyn Napier, Blanda Stammen and Rob Webster. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Hepatology, Archives of Virology, Antiviral Research and Cytometry Part B Clinical Cytometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.